Effect of the prostaglandin synthesis inhibitors indomethacin and eicosa-5,8,11,14-tetraynoic acid on adrenergic responses in dog cutaneous vasculature.
D000818:Animals; D001158:Arteries / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004558:Electric Stimulation; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis* / Q000494:pharmacology; D012867:Skin / Q000098:blood supply* / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000502:physiology*; D013997:Time Factors; D014316:Tritium; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D005231:Fatty Acids, Unsaturated; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D014316:Tritium; D009638:Norepinephrine; D007213:Indomethacin